Form 4 for HUMA Humacyte, Inc.
Accepted 2024-06-17 00:00:00 ET · period of report 2024-06-13 · accession 0001818382-24-000143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-17 | 2024-06-14 | HUMA | Sebelius Kathleen | Dir | M - OptEx | $2.56 | +39.4K | 39.4K | New | +$100.8K |
| D | 2024-06-17 | 2024-06-13 | HUMA | Sebelius Kathleen | Dir | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| D | 2024-06-17 | 2024-06-14 | HUMA | Sebelius Kathleen | Dir | M - OptEx | $0.00 | -39.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | M | A | 39,389 | $2.56 | 39,389 | D | — | — | |
| 2 | Derivative | Stock Options (right to buy) | 2024-06-13 | A | A | 50,000 | $0.00 | 50,000 | D | $7.20 · — to 2034-06-13 | 50,000 Common Stock | (F1) The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028. |
| 3 | Derivative | Stock Options (right to buy) | 2024-06-14 | M | D | 39,389 | $0.00 | 0 | D | $2.56 · 2018-09-01 to 2025-09-01 | 39,389 Common Stock |